Philadelphia, PA, United States of America

Alba Rodriguez-garcia

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alba Rodriguez-garcia. Retrieved from https://idiyas.com/inventor/alba-rodriguez-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alba Rodriguez-Garcia

Introduction

Alba Rodriguez-Garcia is a prominent inventor based in Philadelphia, PA. She has made significant strides in the field of medical research, particularly in the treatment of gynecologic malignancies. Her work is characterized by a commitment to advancing cancer therapies and improving patient outcomes.

Latest Patents

Rodriguez-Garcia holds a patent for her groundbreaking invention titled "MÜLLERIAN INHIBITING SUBSTANCE TYPE 2 RECEPTOR (MISIIR)-SPECIFIC CAR T CELLS FOR THE TREATMENT OF OVARIAN CANCER AND OTHER GYNECOLOGIC MALIGNANCIES." This innovative approach aims to harness the power of CAR T cell therapy to target and treat ovarian cancer effectively. She has 1 patent to her name, showcasing her contributions to the field.

Career Highlights

Alba Rodriguez-Garcia is affiliated with the University of Pennsylvania, where she conducts her research and develops her innovative therapies. Her work at this prestigious institution has positioned her as a leader in the field of cancer research.

Collaborations

Rodriguez-Garcia collaborates with esteemed colleagues, including Daniel J. Powell, who shares her passion for advancing cancer treatment. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Alba Rodriguez-Garcia's contributions to cancer research and her innovative patent highlight her dedication to improving treatment options for patients. Her work continues to inspire future advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…